Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)
Status:
Terminated
Trial end date:
2020-10-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the long-term safety and efficacy of idebenone in
patients with Duchenne muscular dystrophy (DMD) who completed the SIDEROS study.